Also listed on Novartis Inflammasome Research, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jul 23, 2038 · High confidence
20-year base term ends Jul 23, 2038
Jul 23, 2018
Jul 23, 2038
Dec 21, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 23, 2018, when application PCT/US2018/043338, the earliest non-provisional in its chain, was filed (this one was filed Mar 31, 2020) | Jul 23, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,654,816) | resolves to Jul 23, 2038, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 23, 2038 | High confidence |
This family
| Application PCT/US2018/043338 | PCT application no patent term | no patent term |
| US 10,654,816 | In force Jul 2038 | Jul 2038 |
| US 11,203,579 | this patent Jul 2038 | Jul 2038 |
| US 11,724,992 | In force Jul 2038 | Jul 2038 |
| US 12,084,424 | In force Jul 2038 | Jul 2038 |
| Application 18/786,726 | Abandoned not computed | not computed |
| Application 19/074,584 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 20, 2020 Reel 51882, frame 944 | IFM Management, Inc. | Novartis Inflammasome Research, Inc. | Assignment of Assignor's Interest |
| Feb 20, 2020 Reel 51882, frame 980 | Glick, Gary; Roush, William; Venkatraman, Shankar; Shen, Dong-ming; Katz, Jason; Seidel, Hans Martin; Winkler, David Guenther; Ghosh, Shomir; Franchi, Luigi; Opipari, Anthony William, JR. | IFM Management, Inc. | Assignment of Assignor's Interest |
| Feb 5, 2021 Reel 55166, frame 306 | Novartis Inflammasome Research, Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,654,816, ends no earlier than this term, so it caps nothing.